NASDAQ:EXAS
EXACT Sciences Corporation Stock News
$49.84
-4.24 (-7.84%)
At Close: May 24, 2024
Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
10:38am, Friday, 31'st Jul 2020
Exact Sciences (NASDAQ: EXAS) hasn't fired up investors so far in 2020 like it did last year. The good news is that Exact Sciences' management team said that there were signs of improvement in the qu
Wall Street Breakfast: Big Beats From Big Tech
07:04am, Friday, 31'st Jul 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify (click the highlighted links).
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q2 2020 Results - Earnings Call Transcript
11:55pm, Thursday, 30'th Jul 2020
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2020 Earnings Conference Call July 30, 2020 05:00 PM ET Company Participants Megan Jones - Manager, Investor Relations Kevin Conroy - Chairman and Chief Exe
Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates
10:30pm, Thursday, 30'th Jul 2020
Exact Sciences (EXAS) delivered earnings and revenue surprises of 6.45% and 17.09%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Exact Sciences Corporation 2020 Q2 - Results - Earnings Call Presentation
03:36pm, Thursday, 30'th Jul 2020
The following slide deck was published by Exact Sciences Corporation in conjunction with their 2020 Q2 earnings call.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
Should You Buy Exact Sciences (EXAS) Ahead of Earnings?
12:40pm, Wednesday, 29'th Jul 2020
Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Personalis: Buy This Disruptor In Precision Medicine And Machine Learning
09:00am, Monday, 27'th Jul 2020
Company's proprietary NeXT platform is a precision medicine and machine learning analytics platform that helps pharma companies develop new compounds tailored for each patient.
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Should You Buy?
04:32pm, Thursday, 23'rd Jul 2020
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
03:30pm, Thursday, 23'rd Jul 2020
Is (EXAS) Outperforming Other Medical Stocks This Year?
Stocks To Watch: Vaccine Players, Earnings Blitz And Fiscal Debate
08:24am, Saturday, 18'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market
12:00pm, Friday, 17'th Jul 2020
Genetics stocks like Guardant Health and Exact Sciences are launching new genetic tests for cancer that help find cancer earlier and tailor treatments.
Zacks Investment Research Upgrades EXACT Sciences (NASDAQ:EXAS) to Buy
05:20am, Tuesday, 14'th Jul 2020
Zacks Investment Research upgraded shares of EXACT Sciences (NASDAQ:EXAS) from a hold rating to a buy rating in a research report sent to investors on Monday morning, Zacks.com reports. Zacks Investme
EXACT Sciences Co. (NASDAQ:EXAS) Shares Purchased by DNB Asset Management AS
06:24am, Monday, 13'th Jul 2020
DNB Asset Management AS boosted its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 11.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 15,517 shares of the medical research company’s
Did Hedge Funds Make The Right Call On XACT Sciences Corporation (EXAS) ?
01:08am, Saturday, 11'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
